Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study

Clicks: 209
ID: 267579
2012
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Adverse cardiac events occurred in 48.2 % of surgical intensive care unit patients with cardiovascular failure and were related to morbidity and mortality. The extent and duration of catecholamine vasopressor therapy were independently associated with and may contribute to the pathogenesis of advers …
Reference Key
ca2012intensiveadverse Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Schmittinger CA;Torgersen C;Luckner G;Schröder DC;Lorenz I;Dünser MW;;
Journal intensive care medicine
Year 2012
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/22527060##heading
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine female male aged middle aged Prospective Studies pmid:22527060 doi:10.1007/s00134-012-2531-2 Christian A Schmittinger Christian Torgersen Martin W Dünser Catecholamines / adverse effects* Catecholamines / pharmacology* Catecholamines / therapeutic use Heart Rate / drug effects* Myocardial Ischemia / chemically induced* Tachycardia / chemically induced* Vasoconstrictor Agents / adverse effects* Vasoconstrictor Agents / pharmacology* Vasoconstrictor Agents / therapeutic use

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.